First pancreatic cancer patient dosed in Radiopharm study
SYDNEY: Radiopharm Theranostics says it has dosed its first pancreatic cancer patient in the initial
SYDNEY: Radiopharm Theranostics says it has dosed its first pancreatic cancer patient in the initial